Gianpiero Landolfi

Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance

Manuel F. Ugarte‐Gil, Graciela S. Alarcón, Zara Izadi et al. · Annals of the Rheumatic Diseases · 2022 · 92 citations · Full text

Medicine, Internal Medicine, Clinical Epidemiology +14

Overexpression of epidermal growth factor type-1 receptor (EGF-R1) in cervical cancer: Implications for Cetuximab-mediated therapy in recurrent/metastatic disease

Stefania Bellone, Gianluca Frera, Gianpiero Landolfi et al. · Gynecologic Oncology · 2007 · 88 citations

Medicine, Oncology, Pharmacology +17

Bacterial cytosolic proteins with a high capacity for Cu(I) that protect against copper toxicity

Nicolas Vita, Gianpiero Landolfi, Arnaud Baslé et al. · Scientific Reports · 2016 · 67 citations · Full text

Life Sciences, Biochemistry, Microbiology +16

COVID-19 in rheumatic diseases in Italy: first results from the Italian registry of the Italian Society for Rheumatology (CONTROL-19).

Carlo Alberto Scirè, Greta Carrara, Anna Zanetti et al. · PubMed · 2020 · 50 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +11

Intestinal microbiota changes induced by TNF-inhibitors in IBD-related spondyloarthritis

Maria Chiara Ditto, Simone Parisi, Gianpiero Landolfi et al. · RMD Open · 2021 · 28 citations · Full text

Life Sciences, Immunology, Microbiology +17